Podcasts

Christoper Bunick, MD, PhD, provides an update on benzene contamination in sunscreen, including a recent recall from Johnson & Johnson. 

The Cutaneous Connection: Episode 27- Benzene Contamination Update

Articles

The FDA has expanded the label for pembrolizumab for use as a monotherapy in the treatment of patients with locally advanced cutaneous squamous cell carcinoma that is not curable by surgery or radiation.

FDA Approves Pembrolizumab for Locally Advanced cSCC

The European Commission has approved cemiplimab for the treatment of locally advanced or metastatic basal cell carcinoma in adults.

Cemiplimab Approved for BCC in Europe 

Videos

In this video interview, Ted Lain, MD, discusses the causes and effects of actinic keratosis, as well as the unmet needs, how to diagnose, and what treatments are currently available. 

The Current and Emerging Actinic Keratosis Treatment Landscape

In this exclusive interview, Ted Lain, MD, dives into the management of field cancerization, including its biggest challenges, available and emerging treatment options, tips on treatment approach, and more. 

Advances in the Management of Field Cancerization

The Journal of the American Academy of Dermatology has published new recommendations for the treatment of actinic keratosis (AK). 

New Guidelines for Treatment of Actinic Keratosis 

New regulations, latest absorption data, and updates on environmental and health impacts are shaping the world of photoprotection. 

What’s New in Photoprotection?

BCC, SCC treatments take advantage of refinements in established techniques and new technology. 

Treatments Updates for BCC, SCC 

The anti–PD-L1, fully human monoclonal antibody cosibelimab will be examined in a cohort of patients with metastatic cutaneous squamous cell carcinoma (cSCC) as part of an ongoing phase 1 study.

Cosibelimab Being Evaluated for Metastatic cSCC

Christopher Bunick, MD, PhD, associate professor of dermatology, Yale University and Dermatology Times® editorial advisory board member, weighs in on a recent report revealing certain batches of various sunscreen and after-sun care products were contaminated with benzene, a carcinogen. 

Skin Cancer (Nonmelanoma)